Last reviewed · How we verify
NCT04330352
Mindfulness-based "STOP (Stop, Take a Breath, Observe, Proceed) Touching Your Face" Intervention
NA trial testing Mindfulness-based "STOP touching your face" practice in Face-touching Behavior in 1,094 participants. Completed in 2 July 2020.
2 July 2020
Quick facts
| Lead sponsor | Sir Run Run Shaw Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 1,094 |
| Start date | 2 April 2020 |
| Primary completion | 2 July 2020 |
| Estimated completion | 2 July 2020 |
| Sites | 1 location across China |
Drugs / interventions tested
- Mindfulness-based "STOP touching your face" practice
Conditions studied
- Face-touching Behavior — all drugs for Face-touching Behavior →
Sponsor
Sir Run Run Shaw Hospital
Who can join
18 and older, any sex, with Face-touching Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This single-blind, randomized, controlled, trial is to assess the efficasy of a brief mindfulness-based "STOP touching your face" training program to reduce or avoid face-touching to low people's chances of catching infectious diseases like COVID-19.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Brief mindfulness-based intervention of 'STOP (Stop, Take a Breath, Observe, Proceed) touching your face': a study protocol of a randomised controlled trial.
Liao Y, Wang L, Luo T, Wu S, et al · · 2020 · cited 5× · PMID 33234653 · DOI 10.1136/bmjopen-2020-041364 -
Effectiveness of a Brief Mindfulness-Based Intervention of "STOP touching your face" During the COVID-19 Pandemic: a Randomized Controlled Trial.
Tang J, Wang L, Luo T, Wu S, et al · · 2022 · cited 2× · PMID 36408118 · DOI 10.1007/s12671-022-02019-x -
Effectiveness of a Brief Mindfulness-Based Intervention of “STOP" (Stop, Take a Breath, Observe, Proceed) Touching Your Face” During the COVID-19 Pandemic: Randomised Controlled Trial
Tang J, Wang L, Luo T, Wu S, et al · · 2021 · DOI 10.2139/ssrn.3869648
Verify or expand the search:
- PubMed search for NCT04330352
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Sir Run Run Shaw Hospital trials
Trials by the same sponsor.
- NCT07453940 — Left Atrial Appendage Closure With Versus Without Pulsed Field Ablation in Atrial Fibrillation Patients With Mild Sympto · NA · recruiting
- NCT07508943 — Decision-making and Optimization of Ventilatory Support for AECOPD Patients · not yet recruiting
- NCT07514533 — The Efficacy and Safety of Pucotenlimab (PD-1) Combined With Becotatugvedotin (EGFR-ADC) in Advanced Cholangiocarcinoma · Phase 2 · not yet recruiting
- NCT07350590 — Comparison Between Robotic and Laparoscopic Right Hemicolectomy · terminated
- NCT07457073 — AI-Powered Sound Analysis for COPD Screening · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04330352 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sir Run Run Shaw Hospital
- Last refreshed: 30 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04330352.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing